Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
- PMID: 9134596
- DOI: 10.1016/s0920-9964(96)00122-3
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
Abstract
Recent studies have provided evidence for a functional impairment of gamma-aminobutyric acid (GABA)-containing interneurons in the prefrontal cortex of schizophrenics. This evidence includes reported deficits of basket and chandelier cells, which are known to contain the calcium-binding protein parvalbumin. Using a monoclonal antibody against parvalbumin we investigated possible changes in this subpopulation of neurons in the prefrontal cortex of schizophrenic cases and controls. Significantly reduced numbers of parvalbumin-immunoreactive neurons were observed in laminae III and IV, while no difference was detected in cortical width. Our findings are consistent with damage following a toxic insult, occurring during a developmental 'window of vulnerability' and specifically affecting this subpopulation of GABAergic neurons.
Similar articles
-
Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.Biol Psychiatry. 2002 Oct 1;52(7):708-15. doi: 10.1016/s0006-3223(02)01360-4. Biol Psychiatry. 2002. PMID: 12372661
-
Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons.Am J Psychiatry. 1997 Jul;154(7):1013-5. doi: 10.1176/ajp.154.7.1013. Am J Psychiatry. 1997. PMID: 9210755
-
Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients.Psychiatry Res. 1997 Aug 8;75(1):49-59. doi: 10.1016/s0925-4927(97)00020-6. Psychiatry Res. 1997. PMID: 9287373
-
The chandelier neuron in schizophrenia.Dev Neurobiol. 2011 Jan 1;71(1):118-27. doi: 10.1002/dneu.20825. Dev Neurobiol. 2011. PMID: 21154915 Free PMC article. Review.
-
Mapping pathologic circuitry in schizophrenia.Handb Clin Neurol. 2018;150:389-417. doi: 10.1016/B978-0-444-63639-3.00025-6. Handb Clin Neurol. 2018. PMID: 29496154 Review.
Cited by
-
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.Mol Psychiatry. 2013 Nov;18(11):1185-92. doi: 10.1038/mp.2012.137. Epub 2012 Oct 16. Mol Psychiatry. 2013. PMID: 23070074 Free PMC article.
-
Ketamine and phencyclidine: the good, the bad and the unexpected.Br J Pharmacol. 2015 Sep;172(17):4254-76. doi: 10.1111/bph.13222. Epub 2015 Jul 28. Br J Pharmacol. 2015. PMID: 26075331 Free PMC article. Review.
-
Gene-environment interplay in schizopsychotic disorders.Neurotox Res. 2004;6(1):1-9. doi: 10.1007/BF03033291. Neurotox Res. 2004. PMID: 15184100 Review.
-
Are we studying and treating schizophrenia correctly?Schizophr Res. 2011 Aug;130(1-3):1-10. doi: 10.1016/j.schres.2011.05.004. Epub 2011 Jun 8. Schizophr Res. 2011. PMID: 21645998 Free PMC article.
-
Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.Psychopharmacology (Berl). 2008 May;198(1):37-49. doi: 10.1007/s00213-008-1071-5. Epub 2008 Apr 23. Psychopharmacology (Berl). 2008. PMID: 18427784
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
